| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5503970 | Parkinsonism & Related Disorders | 2017 | 7 Pages |
Abstract
In conclusion, intracerebral NTF administration does not improve motor symptoms in PD patients, when compared to placebo-treated controls. These findings may guide therapeutic decisions and inform future research on NTFs and their application in PD.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Shane V. Hegarty, David J. Lee, Gerard W. O'Keeffe, Aideen M. Sullivan,